Kisely Steve, Seth Rebecca, Jordan Susan J, Kendall Bradley, Siskind Dan J, Sara Grant, Chapman Justin, Brophy Lisa, Lawrence David M
The University of Queensland, Brisbane, QLD.
Curtin University, Perth, WA.
Med J Aust. 2024 Dec 9;221(11):617-622. doi: 10.5694/mja2.52521. Epub 2024 Nov 13.
To compare rates of participation in the National Bowel Cancer Screening Program (NBCSP) and follow-up for people with severe mental illness with those for people without severe mental illness or not prescribed antidepressants.
Retrospective cohort study; analysis of de-identified linked NBCSP, Pharmaceutical Benefits Scheme (PBS), and Medicare Benefits Schedule (MBS) data.
Australia, 2006-2019.
People aged 50-74 years (NBCSP-eligible) with severe mental illness, defined as those dispensed two or more prescriptions for second generation antipsychotics or for lithium (PBS data), and a random sample of people aged 50-74 years eligible for Medicare-subsidised services but never prescribed psychotropic medications (antipsychotics, lithium, antidepressants).
NBCSP participation (returned faecal occult blood test sample), valid test result, positive test result, and follow-up colonoscopy rates.
A total of 119 475 people with severe mental illness and 1 090 574 control group people were included in our analyses. The proportion of women was larger in the severe mental illness group (51.3%) than the control group (48.7%), as were the proportions who lived in inner regional areas (23.5% v 19.1%) or in areas in the lowest socio-economic quintile (21.8% v 14.7%). The NBCSP participation rate was lower among people with severe mental illness (adjusted incidence rate ratio [IRR], 0.70; 95% confidence interval [CI], 0.69-0.84). The proportion of valid test results was smaller for people with severe mental illness (95.9% v 98.7%; adjusted IRR, 0.97; 95% CI, 0.96-0.99), and the positive test result proportion larger (12.3% v 6.6%; adjusted IRR, 2.01; 95% CI, 1.94-2.09). The proportion of positive test results followed by colonoscopy was smaller for people with severe mental illness (71.7% v 82.6%; adjusted IRR, 0.88; 95% CI, 0.85-0.92).
People with severe mental illness were less likely to participate in the NBCSP or to undergo colonoscopy after a positive test result than other Australians. These differences may contribute to higher colorectal cancer mortality among people with severe mental illness. The contributions of differences in cancer stage at diagnosis and subsequent treatment to higher colorectal cancer mortality require further study.
比较患有严重精神疾病的人群与未患有严重精神疾病或未服用抗抑郁药物的人群参与国家肠癌筛查计划(NBCSP)及后续跟进的比率。
回顾性队列研究;对去识别化的关联NBCSP、药品福利计划(PBS)和医疗保险福利计划(MBS)数据进行分析。
澳大利亚,2006 - 2019年。
年龄在50 - 74岁(符合NBCSP条件)且患有严重精神疾病的人群,定义为那些被开具两种或更多第二代抗精神病药物或锂盐处方的人(PBS数据),以及年龄在50 - 74岁、有资格享受医疗保险补贴服务但从未服用过精神药物(抗精神病药物、锂盐、抗抑郁药物)的随机抽样人群。
NBCSP参与情况(返回粪便潜血试验样本)、有效检测结果、阳性检测结果以及后续结肠镜检查比率。
我们的分析共纳入了119475名患有严重精神疾病的人群和1090574名对照组人群。严重精神疾病组中女性比例(51.3%)高于对照组(48.7%),居住在区域内城区的比例(23.5%对19.1%)以及居住在社会经济最底层五分之一区域的比例(21.8%对14.7%)也是如此。患有严重精神疾病的人群中NBCSP参与率较低(调整后的发病率比[IRR]为0.70;95%置信区间[CI]为0.69 - 0.84)。患有严重精神疾病的人群中有效检测结果的比例较小(95.9%对98.7%;调整后的IRR为0.97;95%CI为0.96 - 0.99),而阳性检测结果的比例较大(12.3%对6.6%;调整后的IRR为2.01;95%CI为1.94 - 2.09)。检测结果呈阳性后接受结肠镜检查的患有严重精神疾病的人群比例较小(71.7%对82.6%;调整后的IRR为0.88;95%CI为0.85 - 0.92)。
与其他澳大利亚人相比,患有严重精神疾病的人群参与NBCSP或检测结果呈阳性后接受结肠镜检查的可能性较小。这些差异可能导致患有严重精神疾病的人群中结直肠癌死亡率较高。诊断时癌症分期及后续治疗差异对较高的结直肠癌死亡率的影响需要进一步研究。